Tiny Red HandsBack

VA clinicians warned more than 1,000 veterans could lose access to research treatment

Date
2025-05-06
Entry type
veterans-care-disruption
Current status
Some decisions were reversed, but several trials remained stalled

Clinical-trial interruptions affect patients with metastatic cancer, kidney disease, brain injury, and other conditions lacking standard options.

Entities and roles

Relationships in this file

  1. Elon Muskcut contracts and staff needed for research treatmentU.S. Department of Veterans Affairs
  2. Donald J. TrumpTrump-appointed senior adviser who led DOGE workElon Musk
  3. Donald J. TrumpTrump-appointed OMB director and acting CFPB directorRussell Vought

Claims and evidence

  1. factreported

    Internal VA warnings obtained by ProPublica said cuts could deprive more than 1,000 veterans of access to treatment studies; the administration restored some work, but advanced head-and-neck cancer trials remained stalled.

  2. factdocumented

    Elon Musk was the Trump-appointed senior adviser who led DOGE work.

  3. factdocumented

    Russell Vought was the Trump-appointed OMB director and acting CFPB director.

Measurements

  1. Veterans warned at risk of losing research treatmentmore than 1,000 people
    Basis
    Observed
    Population
    Veterans in affected VA studies identified by internal warnings
    Period
    2025-01-20 to 2025-05-06
    Method
    Count in internal VA issue briefs obtained by ProPublica.
    Uncertainty
    Prospective exposure count; some trials and positions were later restored.